0001578563-17-000006.txt : 20170419 0001578563-17-000006.hdr.sgml : 20170419 20170419140755 ACCESSION NUMBER: 0001578563-17-000006 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170419 DATE AS OF CHANGE: 20170419 EFFECTIVENESS DATE: 20170419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Fortress Biotech, Inc. CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 205157386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-285127 FILM NUMBER: 17769621 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET STREET 2: 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC DATE OF NAME CHANGE: 20080310 D 1 primary_doc.xml X0707 D LIVE 0001429260 Fortress Biotech, Inc. 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY NEW YORK 10014 781-652-4500 DELAWARE CORONADO BIOSCIENCES INC Corporation true Lindsay A. Rosenwald c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Executive Officer Director Michael S. Weiss c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Lucy Lu c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Executive Officer Jimmie Harvey, Jr. c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Malcolm Hoenlein c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director J. Jay Lobell c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Eric K. Rowinsky c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director George Avgerinos c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Executive Officer Dov Klein c/o 2 Gansevoort Street 9th Floor New York NY NEW YORK 10014 Director Biotechnology Decline to Disclose 06b false 2017-03-31 false true true false 0 National Securities Corporation 7569 National Securities Corporation 7569 410 Park Avenue 14th Floor New York NY NEW YORK 10022 All States false Indefinite 3254000 Indefinite false 2 325400 0 In addition to the cash commission above, Issuer also issued warrants to purchase 87,946 shares of the Company's common stock at an exercise price of $3.70 per share. 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false Fortress Biotech, Inc. /s/ Lindssay A. Rosenwald, MD Lindsay A. Rosenwald, MD President and Chief Executive Officer 2017-04-19